Terry van der Tuuk is Director at HEMACARE CORP /CA/ (HEMA). They have made 7 open-market trades across 2 companies since 2006, most recently 2011-09-15.
CIK 0001232812
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
3 open-market purchases totalling $117K since 2008, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| HEMA | BUY | 2011-09-15 | 2011-09-23 | $0.28 | $28K | N/A | N/A | N/A |
| HEMA.OB | BUY | 2010-09-09 | 2010-09-13 | $0.52 | $2K | N/A | N/A | N/A |
| HEMA.OB | BUY | 2008-03-25 | 2008-03-26 | $0.29 | $87K | N/A | N/A | N/A |
| HEMA | SELL | 2006-12-29 | 2007-01-10 | $2.95 | $6K | N/A | N/A | N/A |
| HEMA | SELL | 2006-03-15 | 2006-03-15 | $2.52 | $82K | N/A | N/A | N/A |
| HEMA | SELL | 2006-03-10 | 2006-03-13 | $2.41 | $27K | N/A | N/A | N/A |
| HEMA | SELL | 2006-03-07 | 2006-03-10 | $2.46 | $16K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.